MedPath

Efficacy of Humira(Adalimumab) in patients with moderate to severe ulcerative colitis (KyuSyu IBD project)

Not Applicable
Recruiting
Conditions
lcerative colitis
Registration Number
JPRN-UMIN000019512
Lead Sponsor
Fukuoka University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who Contraindicate for adalimumab. 2.Patients who can not provide informed consent. 3.Patients who have malignancy 4.Patients who judged to be disqualified by the physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath